Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial. Issue 3 (March 2015) - Levy, Antonin; Azria, David; Pignon, Jean-Pierre; Delarochefordiere, Anne; Martel-Lafay, Isabelle; Rio, Emmanuel; Malka, David; Conroy, Thierry; Miglianico, Laurent; Becouarn, Yves; Malekzadeh, Katty; Leclercq, Julie; et al.